Urgent need to minimize blood loss in patients and increase in cases of surgical procedures occurring across different countries are the key factors driving the growth of the surgical sealants and adhesives market. Furthermore, surge in adoption of technological advanced products along with certification by regulatory authorities is expected to boost the market growth. However, improper reimbursements in case of surgical adhesive and high costs along with huge data requirements for clinical study designing & launching new products are the factors that hamper the growth of the market. On the contrary, upsurge in demand for surgical sealants & adhesives across the emerging nations is anticipated to offer lucrative growth opportunities for the market.
The global surgical sealants and adhesives market is segmented based on product, indication, application, and region. On the basis of product, the market is bifurcated into natural/biological sealants & adhesives and synthetic & semisynthetic sealants and adhesives. Natural/biological sealants and adhesives are further segmented into by type and by origin. By type, natural/biological sealants and adhesives are classed into polypeptide/protein-based sealants & adhesives and polysaccharide-based sealants & adhesives. Polypeptide/protein-based sealants and adhesives are subsegmented into fibrin based, collagen based, based, and albumin based. Polysaccharide-based sealants and adhesives are further classified into chitosan based and other polysaccharide based. By origin, natural/biological sealants and adhesives are divided into animal based, human based, and plant based. Synthetic & semisynthetic sealants and adhesives are further segmented into cyanoacrylates, polyethylene glycol-based hydrogel, urethane-based adhesives, and other synthetic sealants and adhesives. The market based on indication is fragmented into tissue sealing & hemostasis and tissue engineering. The applications covered in the study include central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
This report offers a detailed quantitative analysis of the current trends and future estimations from 2016 to 2023 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
Natural/Biological Sealants and Adhesives
Polypeptide/Protein-based Sealants and Adhesives
Polysaccharide-based Sealants and Adhesives
Other Polysaccharide Based
Human Blood Based
Synthetic and Semisynthetic Sealants and Adhesives
Polyethylene Glycol-based Hydrogel
Other Synthetic Sealants and Adhesives
Tissue Sealing and Hemostasis
Central Nervous System (CNS) Surgeries
Rest of Europe
Rest of Asia-Pacific
Republic of South Africa
Rest of LAMEA
KEY PLAYERS PROFILED
Baxter International Inc.
B. Braun Melsungen AG
Cohera Medical, Inc.
C.R. Bard Inc.
CSL Limited (CSL Behring)
Johnson & Johnson (Ethicon, Inc.)
Ocular Therapeutix Inc.
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top winning strategies, by year, 2015-2018*
3.2.4. Top winning strategies, by development, 2015-2018* (%)
3.2.5. Top winning strategies, by company, 2015-2018*
3.3. Porters five forces analysis
3.4. Top player positioning, 2016
3.5. Market dynamics
22.214.171.124. Increase in ageing population and rise in awareness towards surgical sealants and adhesives
126.96.36.199. Surge in prevalence of chronic diseases and rise in surgical procedures conducted globally
188.8.131.52. Surge in adoption of technologically advanced products
184.108.40.206. High cost and extensive clinical data required for the launch of new surgical sealants and adhesives
220.127.116.11. Popularity of minimally invasive surgeries
18.104.22.168. Introduction of novel surgical sealants and adhesives and rise in healthcare spending
CHAPTER 4: SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT
4.2. Market size and forecast
4.3. Natural/biological surgical sealants and adhesives
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Natural/biological sealants and adhesives, by type
22.214.171.124. Market size and forecast
126.96.36.199. Polypeptide/protein-based sealants and adhesives
188.8.131.52.1. Market size and forecast
184.108.40.206.2. Fibrin based
220.127.116.11.2.1. Market size and forecast
18.104.22.168.3. Collagen based
22.214.171.124.3.1. Market size and forecast
126.96.36.199.4. Gelatin based
188.8.131.52.4.1. Market size and forecast
184.108.40.206.5. Albumin based
220.127.116.11.5.1. Market size and forecast
18.104.22.168. Polysaccharide-based sealants and adhesives
22.214.171.124.1. Market size and forecast
126.96.36.199.2. Chitosan based
188.8.131.52.2.1. Market size and forecast
184.108.40.206.3. Other polysaccharide based
220.127.116.11.3.1. Market size and forecast
4.3.4. Natural/biological sealants and adhesives, by origin
18.104.22.168. Market size and forecast
22.214.171.124. Human blood based
126.96.36.199.1. Market size and forecast
188.8.131.52. Animal based
184.108.40.206.1. Market size and forecast
220.127.116.11. Plant based
18.104.22.168.1. Market size and forecast
4.4. Synthetic & semisynthetic sealants and adhesives
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market size and forecast
22.214.171.124. Market size and forecast
4.4.5. Polyethylene glycol-based hydrogel
126.96.36.199. Market size and forecast
4.4.6. Urethane-based adhesives
188.8.131.52. Market size and forecast
4.4.7. Other synthetic sealants and adhesives
184.108.40.206. Market size and forecast
CHAPTER 5: SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION
5.1.1. Market size and forecast
5.2. Central nervous system (CNS) surgeries
5.2.1. Market size and forecast, by region
5.3. General surgeries
5.3.1. Market size and forecast, by region
5.4. Cardiovascular surgeries
5.4.1. Market size and forecast, by region
5.5. Orthopedic surgeries
5.5.1. Market size and forecast, by region
5.6. Cosmetic surgeries
5.6.1. Market size and forecast, by region
5.7. Ophthalmic surgeries
5.7.1. Market size and forecast, by region
5.8. Urological surgeries
5.8.1. Market size and forecast, by region
5.9. Pulmonary surgeries
5.9.1. Market size and forecast, by region
5.10.1. Market size and forecast, by region
CHAPTER 6: SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION
6.1.1. Market size and forecast
6.2. Tissue sealing & hemostasis
6.2.1. Market size and forecast, by region
6.3. Tissue engineering
6.3.1. Market size and forecast, by region
CHAPTER 7: SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by product
7.2.3. Market size and forecast, by indication
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country
220.127.116.11. U.S. market size and forecast
18.104.22.168. Canada market size and forecast
22.214.171.124. Mexico market size and forecast
7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by product
7.3.3. Market size and forecast, by indication
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by country
126.96.36.199. Germany market size and forecast
188.8.131.52. UK market size and forecast
184.108.40.206. France market size and forecast
220.127.116.11. Italy market size and forecast
18.104.22.168. Spain market size and forecast
22.214.171.124. Rest of Europe market size and forecast
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by product
7.4.3. Market size and forecast, by indication
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by country
126.96.36.199. Japan market size and forecast
188.8.131.52. China market size and forecast
184.108.40.206. India market size and forecast
220.127.116.11. Australia market size and forecast
18.104.22.168. South Korea market size and forecast
22.214.171.124. Rest of Asia-Pacific market size and forecast
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by product
7.5.3. Market size and forecast, by indication
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by country
126.96.36.199. Brazil market size and forecast
188.8.131.52. South Africa market size and forecast
184.108.40.206. Saudi Arabia market size and forecast
220.127.116.11. Rest of LAMEA market size and forecast
CHAPTER 8: COMPANY PROFILES
8.1. Baxter International Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. B. Braun Melsungen AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Cohera Medical, Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Key strategic moves and developments
8.4. CryoLife Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. C.R. Bard Inc.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. CSL Limited (CSL Behring)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Johnson & Johnson (Ethicon, Inc.)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Ocular Therapeutix Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Business performance
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. Sealantis Ltd.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments
Adhesives and sealants are used during surgical procedures to reinforce surgical wounds, repair injured tissues, or even replace common suturing techniques. These products can be used as adjuncts to sutures to prevent air and liquid leakages. They can be developed naturally or synthetically, and are used generate three-dimensional networks, which bind to the target tissues and act as sealants, hemostats, or adhesives.
The major driving factors of surgical sealants and adhesives market are rise in geriatric population, surge in prevalence of chronic diseases, and increase in awareness towards the benefits of using surgical sealants and adhesives. Furthermore, increase in number of surgical procedures globally and adoption of technologically advanced products fuel the growth of this market. However, rise in popularity of minimally invasive surgeries, high cost of these sealants and adhesive agents, and requirement of large amount of clinical data for the launch of new products are expected to hamper the market growth.
Among the product segment, natural sealants and adhesives dominates the market, as these products cause less immunogenic reaction, are available abundantly, and are thus less expensive as compared to synthetic products. However, the synthetic and semisynthetic sealants and adhesives segment registers the highest growth rate, as these products are more durable and flexible in nature.
Among the indication segment, tissue engineering is anticipated to grow at the highest rate, owing to upsurge in demand for tissue regeneration products in case of traumatic & burn injuries and rise in number of cosmetic surgeries.
According to Garima Chandra, Research Analyst, Healthcare at Allied Market Research, Increase in number of surgical procedures globally, surge in demand to minimize blood loss in patients, and increase in awareness towards the potential benefits of using surgical sealants and adhesives over traditional methods are the major driving factors of the market.
Key findings of the Surgical Sealants and Adhesives Market:
Cosmetic surgery is projected to grow at the highest rate during the forecast period both in terms of value and volume by 12.2% and 12.7% respectively.
North America dominated the global surgical sealants and adhesives market in 2016, and is projected to continue its dominance in future.
China is expected to grow at the highest rate in the Asia-Pacific region during the forecast period.
Tissue sealing & hemostasis was the largest contributor among the end user segment in 2016.
Cardiovascular surgery segment generated the highest revenue in 2016, and is expected to continue its dominance in future.
In terms of volume fibrin based accounted for the largest share in 2016, registering a CAGR of 8.5% during the forecast period.
Chitosan based dominated the polysaccharide natural surgical sealants and adhesive segment in terms of volume in 2016.
In 2016, North America was the dominant revenue contributor, owing to high prevalence of chronic diseases, increase in disposable income, and surge in number of surgical procedures. However, Asia-Pacific is witnessing the highest CAGR during the analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the prevalence rate of chronic diseases, geriatric population, and the number of cosmetic surgeries being conducted.
The key players operating in the global surgical sealants and adhesives market include Baxter International Inc., B. Braun Melsungen AG, Cohera Medical, Inc., CryoLife Inc., C.R. Bard Inc., CSL Limited (CSL Behring), Johnson & Johnson (Ethicon, Inc.), Ocular Therapeutix Inc., Sanofi, and Sealantis Ltd.
Other prominent players in the value chain include Vivostat A/S, Medtronic plc, Mallinckrodt plc, Cardinal Health, Integra LifeSciences Holdings Corporation, and LifeBond Ltd.
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.